Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications
β Scribed by Robert A. Lahti; Dawna L. Evans; Nancy C. Stratman; Lana M. Figur
- Book ID
- 115888598
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 366 KB
- Volume
- 236
- Category
- Article
- ISSN
- 0014-2999
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The identification of a novel dopamine receptor subtype, referred to as the D4 receptor, which binds the atypical antipsychotic drug clozapine with high potency, has led to the initiation of a drug discovery program that aims to find novel inhibitors of this receptor subtype. A selective screening s
The actions on central dopamine (DA) mechanisms of raclopride, a new substituted benzamide, were studied by means of behavioural and biochemical methods in the rat. Raclopride blocked the in vitro binding of the dopamine D2 antagonist 3H-spiperone (ICso = 32 nM), but not of the unselective D1 antago
Seeman, P., D.E. Grigoriadis, and H.B. Niznik: Selectivity of agonists and antagonists at D2 dopamine receptors compared to D, and S2 receptors. Drug Dev. Res. 9:63-69, ## 1986. The common dopamine agonists (dopamine, apomorphine, ADTN, and N-propylnorapomorphine) are not selective for either D,